Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

University of North Carolina Lineberger Comprehensive Cancer Center researcher and two other experts endorsed the Center for Medicare & Medicaid Services' (CMS) requirement for a patient and their doctor to engage in a shared discussion of benefits and harms before proceeding with a low-dose spiral computed tomography (LDCT) scan as a method for preventing lung cancer death
News | Lung Imaging
Experts Recommend Shared Patient - Doctor Decision-making Prior to Lung Cancer Screening

March 10, 2021 — In a viewpoint perspective published in JAMA on March 9, 2021, a University of North Carolina ...

Time March 10, 2021
arrow
Stefan Vilsmeier Brainlab announced the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops image reading and reporting software for clinical routine and research
News | Treatment Planning
Brainlab Acquires Mint Medical

March 10, 2021 — Brainlab announced the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops image ...

Time March 10, 2021
arrow
Methodology for evaluation of tumor cell density (TCD) and allocation of radiotherapy response categories. (A) Virtual graticule of approximately 300 points applied to tumor area on a digital H&E section. (B) Demonstration of TCD point scoring. (C) Box and whisker plot to show the relationship between ΔTCD and American Joint Committee on Cancer (AJCC) Tumour Regression Grade System (TRG). (D, E) Allocation of three radiotherapy response groups according to change in TCD (ΔTCD) for short-course radiotherapy
News | Radiation Oncology
Targeted Immunotherapy Could Boost Radiotherapy Response

March 9, 2021 — Cancers that are resistant to radiotherapy could be rendered susceptible through treatment with ...

Time March 09, 2021
arrow
Axial fused PET/CT image shows intense uptake (arrowhead) in the deep pelvis corresponding to the left lobe of the prostate in a 62-year-old with a history of prostate cancer treated with radiation therapy. The CT scan does not show the tumor. Image courtesy of the the Radiological Society of North America.
Feature | Treatment Planning | By Melinda Taschetta-Millane
Using PET to Enhance Prostate Treatment Planning

The decision to offer radiation after prostatectomy for patients with recurrent prostate cancer is quite complex, and ...

Time March 05, 2021
arrow
A single image of a human brain using a magnetic resonance imaging (MRI) machine. Image courtesy of Dr Leon Kaufman. University Of California, San Francisco
News | Ultrasound Imaging
New Cancer Scan Could Guide Brain Surgery

March 3, 2021 — A type of ultrasound scan can detect cancer tissue left behind after a brain tumor is removed more ...

Time March 03, 2021
arrow
“Distinction in Stereotactic Radiotherapy” offers comprehensive accreditation program for SRS/SBRT clinical practice and physics quality assurance
News | Stereotactic Body Radiation Therapy (SBRT)
The Radiosurgery Society Announces Launch of Joint Accreditation Program with The American College of Radiation Oncology

February 26, 2021 — The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and ...

Time February 26, 2021
arrow
AiCure, an AI and data analytics company focused on improving clinical trials, and OncoBay Clinical, a full-service boutique contract research organization (CRO) specializing in the simplification of complex oncology programs, today announced a strategic partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development.
News | Artificial Intelligence
AiCure and OncoBay Clinical Partner to Improve Oncology Clinical Trials and Patient Care

February 25, 2021 — AiCure, an AI and data analytics company focused on improving clinical trials, and OncoBay Clinical ...

Time February 25, 2021
arrow
F-18 FES PET images of patients with ER+/PR+/HER2- invasive ductal carcinoma. Left panel: Progressive disease seen at the 8-week time-point in a patient on sequential therapy. Right panel: Stable disease through all 3 time-points, remaining on study therapy for 6.7 months until disease progression on combined vorinostat aromatase inhibitor therapy. Image created by Lanell M Peterson, Research Scientist, University of Washington Medical Oncology, Seattle WA.
News | Molecular Imaging
Molecular Imaging Determines Effectiveness of Novel Metastatic Breast Cancer Treatment

February 22, 2021 — Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2 ...

Time February 22, 2021
arrow
Immunotherapy-based precision medicine clinical trials being developed
News | Prostate Cancer
Why Black Men's Prostate Cancer May be More Responsive to Immunotherapy

February 16, 2021 — Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from ...

Time February 16, 2021
arrow
ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized ZAP-X Gyroscopic Radiosurgery platform.
News | Stereotactic Body Radiation Therapy (SBRT)
ZAP Surgical Builds Market for its Novel ZAP-X Gyroscopic Radiosurgery Platform

February 12, 2021 — ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized ...

Time February 12, 2021
arrow
News | Breast Imaging
Female Breast Cancer Surpasses Lung as the Most Commonly Diagnosed Cancer Worldwide

February 8, 2021 — Cancer ranks as a leading cause of death in every country in the world, and, for the first time ...

Time February 08, 2021
arrow
Phase III clinical trial of men with a clinical suspicion of prostate cancer finds MRI with targeted biopsies to be more accurate at diagnosis and less intrusive than current standard
News | Magnetic Resonance Imaging (MRI)
Using MRI for Prostate Cancer Diagnosis Equals or Beats Current Standard

February 8, 2021 — The results of a Phase III randomized clinical trial have shown that when it comes to detecting ...

Time February 08, 2021
arrow
Real Time Imaging Technologies LLC iannounced that it has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND METHODS which covers the company’s methods for incorporating microlens into X-ray imaging detectors that enables significantly lower radiation dose without compromising image resolution.
News | Radiation Dose Management
New Imaging Intellectual Property for Lower Radiation Dose

February 5, 2021 — Real Time Imaging Technologies LLC has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND ...

Time February 05, 2021
arrow
News | Prostate Cancer
Ultrasound Technique Treats Prostate Cancer with Minimal Side Effects

February 5, 2021 — A technique that delivers high-intensity focused ultrasound to targeted tissue under MRI guidance ...

Time February 05, 2021
arrow
 GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom — announced the addition of a game-changing adaptive therapy, the Ethos.
News | Radiation Therapy
GenesisCare Brings Florida Cancer Patients First-of-its-Kind Ethos Adaptive Intelligence Technology

February 4, 2021 — GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the ...

Time February 04, 2021
arrow
Bright spots indicate that cancer cells have responded to a one-day challenge with estrogen in this positron emission tomography (PET) scan of a woman with breast cancer. In a small study, researchers at Washington University School of Medicine in St. Louis found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients. Image courtesy of Farrokh Dehdashti
News | PET Imaging
Imaging Identifies Breast Cancer Patients Unlikely to Benefit from Hormone Therapy

February 3, 2021 — Hormone therapy commonly is given as a targeted treatment for women whose cancer cells carry ...

Time February 03, 2021
arrow
Ludwig Chicago Co-director Ralph Weichselbaum and Kaiting Yang, a postdoctoral researcher in Weichselbaum's lab.
News | Radiation Therapy
Ludwig Cancer Research Study Reveals How Certain Gut Bacteria Compromise Radiotherapy

January 28, 2021 — A study led by Ludwig Chicago Co-director Ralph Weichselbaum, M.D., and Yang-Xin Fu, M.D., Ph.D., of ...

Time January 28, 2021
arrow
Aquilion Exceed LB CT System offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT)
Canon Medical’s AI-Powered, Premium Large Bore CT Receives FDA Clearance

Janaury 25, 2021 —Canon Medical Systems USA, Inc. has received FDA clearance for the Aquilion Exceed LB CT system ...

Time January 25, 2021
arrow
An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost, as shown by a large-scale study initiated by UMC Utrecht in collaboration with the Netherlands Cancer Institute, UZ Leuven and Radboudumc.
News | Prostate Cancer
Radiation Boost Lowers Risk of Prostate Cancer Recurrence

January 25, 2021 — An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects ...

Time January 25, 2021
arrow
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.
Feature | Prostate Cancer | By Brian Wodlinger, Ph.D.
Detecting Prostate Cancer With Advanced Micro-ultrasound

Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next ...

Time January 20, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now